Concepedia

Author

Alan B. Miller

University of FloridaORCID

Also Known As

A MILLER, A Miller, A. B. Miller, A. Miller, A.B. Miller, ALAN B. MILLER, Alan B Miller, Alan B. Miller, Alan Bruce Miller, Alan Miller

173

Publications

9K

Citations

35

H-Index

70

Concepts

All Affiliations

University of FloridaJacksonville UniversityUniversity of Florida Health Science CenterDuke UniversityClinical Research Institute
AB

About

Alan B. Miller is an author at University of Florida specializing in medicine, cardiology, and cardiovascular disease.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

26

34

4.7K

2

Public Health

10

10

559

3

Health Sciences

5

5

511

4

Applied Physiology

1

1

14

5

Biomedical Engineering

1

1

69

Alan B. Miller

×

56

Publications

8.1K

Citations

32

H-Index

YearCitations

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed,

The Lancet

2018

1.7K

Effect of Amlodipine on Morbidity and Mortality in Severe Chronic Heart Failure

Milton Packer, Christopher M. O’Connor, Jalal K. Ghali,

New England Journal of Medicine

1996

1.2K

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

Carel W. le Roux, Arne Astrup, Ken Fujioka,

The Lancet

2017

813

Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction

Milton Packer, Stefan D. Anker, Javed Butler,

Circulation

2020

408

Diuretic resistance predicts mortality in patients with advanced heart failure

Gerald W. Neuberg, Alan B. Miller, Chris O’Connor,

American Heart Journal

2002

368

Body Mass Index and Adverse Cardiovascular Outcomes in Heart Failure Patients With Preserved Ejection Fraction

Markus Haass, Dalane W. Kitzman, Inder S. Anand,

Circulation Heart Failure

2011

355

Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial

Milton Packer, Javed Butler, Faı̈ez Zannad,

Circulation

2021

332

Mode of Death in Patients With Heart Failure and a Preserved Ejection Fraction

Michael R. Zile, William H. Gaasch, Inder S. Anand,

Circulation

2010

326

Can physicians always explain the results of clinical trials? a case study of amlodipine in heart failure

Milton Packer, Alan B. Miller

The American Journal of Cardiology

1999

277

Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: Results from efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan (EVEREST) program

Christopher M. O’Connor, Alan B. Miller, John E. Blair,

American Heart Journal

2010

233

Page 1